Search
Search Results
-
Racial and Ethnic Disparities in Implantable Cardioverter-Defibrillator Utilization: A Contemporary Review
Purpose of reviewSudden cardiac arrest is associated with high morbidity and mortality. Despite having a disproportionate burden of sudden cardiac...
-
Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy
BackgroundPrimary prophylactic implantable cardioverter-defibrillators (ICDs) in patients with non-ischaemic cardiomyopathy (NICMP) remains...
-
Implantable cardioverter defibrillator and cardiac resynchronization treatment in people with type 2 diabetes: a comparison with age- and sex matched controls from the general population
BackgroundIncreased risk of severe tachyarrhythmias is reported in patients with type 2 diabetes mellitus (T2DM). The aim of this study was to...
-
Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial
BackgroundSodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death with type 2...
-
Predictors of appropriate therapies delivered by the implantable cardioverter-defibrillator in patients with coronary artery disease during long-term period
This prospective study aimed to investigate the ability of cardiac autonomic nervous system (CANS) activity assessment to predict appropriate...
-
Comparison and predictors of implantable cardioverter-defibrillator therapy for primary and secondary prevention
BackgroundImplantable cardioverter-defibrillators (ICDs) are effective in detecting and treating ventricular arrhythmias. Studies on ICD therapy for...
-
Combined subcutaneous implantable cardioverter defibrillator and pacemaker devices in complex congenital heart disease: a single-center experienced based study
BackgroundSubcutaneous implantable cardioverter defibrillators (S-ICD) are widely accepted therapy in congenital heart disease (CHD) patients at risk...
-
Metabolomics Profiling Predicts Ventricular Arrhythmia in Patients with an Implantable Cardioverter Defibrillator
Implantable cardioverter defibrillators (ICDs) reduce sudden cardiac death (SCD) when patients experience life-threatening ventricular arrhythmias...
-
“Real-world” analysis of battery longevity of implantable cardioverter-defibrillators: an in-depth analysis of a prospective defibrillator database
BackgroundThere is a lack of evidence regarding contemporary implantable cardioverter-defibrillator (ICD) battery longevity. Our aim was to assess...
-
Transvenous or subcutaneous implantable cardioverter defibrillator: a review to aid decision-making
The implantable cardioverter-defibrillator (ICD) is a proven treatment for preventing sudden cardiac death. Transvenous leads are associated with...
-
Virtual Reality for the Management of Pain and Anxiety in Patients Undergoing Implantation of Pacemaker or Implantable Cardioverter Defibrillator: A Randomized Study
BackgroundThe Virtual Reality Headset (VRH) is a device aiming at improving patient’s comfort by reducing pain and anxiety during medical...
-
Intermuscular two-incision technique for implantation of the subcutaneous implantable cardioverter defibrillator: a 3-year follow-up
PurposeThe aim of the present study was to evaluate the outcome of patients underwent subcutaneous implantable cardioverter defibrillator (S-ICD)...
-
-
Addressing PTSD in Implantable Cardioverter Defibrillator Patients: State-of-the-Art Management of ICD Shock and PTSD
Purpose of ReviewThis paper reviews the unique processes and treatments of post-traumatic stress in implantable cardioverter-defibrillator (ICD)...
-
-
Topological data analysis to identify cardiac resynchronization therapy patients exhibiting benefit from an implantable cardioverter-defibrillator
BackgroundCurrent guidelines recommend considering multiple factors while deciding between cardiac resynchronization therapy with a defibrillator...
-
Implantation of a VDD implantable cardioverter-defibrillator lead via a persistent left superior vena cava
A persistent left superior vena cava (LSVC) represents a challenging congenital abnormality for transvenous cardiac device implantation. In the...
-
Subcutaneous implantable cardioverter defibrillator after transvenous lead extraction: safety, efficacy and outcome
BackgroundSubcutaneous implantable cardioverter defibrillator (S-ICD) is a suitable alternative for transvenous ICD (TV-ICD) patients who have...
-
Arrhythmogenicity of anti-tachycardia pacing in patients with implantable cardioverter defibrillator
BackgroundAnti-tachycardia pacing therapy (ATP) has shown comparable efficacy to shock therapy in ventricular tachycardia (VT) termination with...
-
Secondary prevention implantable cardioverter-defibrillator (ICD) therapy: value in octogenarians
BackgroundImplantable cardioverter-defibrillator (ICD) therapy is well established for secondary prevention, but studies on the efficacy and safety...
